Aridis Pharmaceuticals, Inc. (11) | License Agreements (3)
Recent Contracts
-
Exclusive License Agreement dated September 10, 2020 by and between Aridis Pharmaceuticals, Inc. and UAB Research Foundation
(Filed With SEC on November 23, 2020)
-
License, Development and Commercialization Agreement between Aridis Pharmaceuticals, Inc. and Serum AMR Products, entered into as of September 27, 2019
(Filed With SEC on October 3, 2019)
-
Option Agreement for Exclusive Product and Platform Technology License between Aridis Pharmaceuticals, Inc. and Serum International BV, dated July 16, 2019
(Filed With SEC on July 30, 2019)
